0,1,2,3,4,5,6,7,8
"Table 5: Resistance prevalence of eight common bacteria, U.S. (all patients pooled), 1999â€“2002",,,,,,,,
,,,,unit: %,,,,
Bacterium,Resistant to,,1999,2000,2001,2002,Average,Average
,antibiotic(s),,,,,,Resistance,Growth Rate
PAE,Ciprofloxacin,,23,25,28,29,26,8
,/ofloxacin,,,,,,,
,Levofloxacin,,29,30,31,30,30,1
,Imipenem,,12,12,15,13,13,4
,Ceftazidime,,8,8,9,9,9,4
,Piperacillin,,10,10,11,12,11,6
SAU (MRSA),Methicillin,,32,35,38,39,36,7
Enterococcus,Vancomycin,,11,8,10,10,10,-1
spp,,,,,,,,
ECO,Cef3,,1,1,1,1,1,0
,Quinolone,,2,3,4,5,4,36
KPN,Cef3,,4,4,4,5,4,8
Enterobacter,Cef3,,19,19,18,19,19,0
spp,,,,,,,,
,Carbapenum,,1,1,1,1,1,0
CNS,Methicillin,,60,61,62,63,62,2
Pneumococcu,Penicillin,,14,16,19,19,17,11
s spp,,,,,,,,
,Cef3,,5,8,7,7,7,16
,,Mean:,,,,,17,7
